In vivo mesenchymal stem cell tracking with PET using the dopamine type 2 receptor and 18F-fallypride

Journal of Nuclear Medicine

Volumn 55, Issue 8, 2014, Pages 1342-1347

  Schönitzer, Veronika ^a   Haasters, Florian ^a   Käsbauer, Stefanie ^a   Ulrich, Veronika ^a   Mille, Erik ^a   Gildehaus, Franz Josef ^a   Carlsen, Janette ^a   Pape, Manuela ^a   Beck, Roswitha ^a   Delker, Andreas ^a   Böning, Guido ^a   Mutschler, Wolf ^a   Böcker, Wolfgang ^a   Schieker, Matthias ^a   Bartenstein, Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell tracking; Dopamine 2 receptor; In vivo imaging; Mesenchymal stem cells; Positron emission tomography

Indexed keywords

DOPAMINE 2 RECEPTOR; FLUORINE FALLYPRIDE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; DRD2 PROTEIN, HUMAN; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; PYRROLIDINE DERIVATIVE;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRACKING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEASIBILITY STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; MESENCHYMAL STEM CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CYTOLOGY; DIAGNOSTIC USE; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MUTATION; RAT; SCINTISCANNING; TRANSGENE;

ANIMALS; BENZAMIDES; CELL TRACKING; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MUTATION; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RATS; RECEPTORS, DOPAMINE D2; TRANSGENES;

EID: 84905442246     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.134775     Document Type: Article

References (38)

1. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7:259-264.
2. Drosse I, Volkmer E, Capanna R, De Biase P, Mutschler W, Schieker M. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury. 2008;39(suppl 2):S9-S20.
3. Kassem M. Stem cells: potential therapy for age-related diseases. Ann N Y Acad Sci. 2006;1067:436-442.
4. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
5. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71-74.
6. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res. 1998; (355, suppl): S247-S256.
7. Schantz JT, Hutmacher DW, Lam CX, et al. Repair of calvarial defects with customised tissue-engineered bone grafts II: evaluation of cellular efficiency and efficacy in vivo. Tissue Eng. 2003;9(suppl 1):S127-S139.
8. Xian CJ, Foster BK. Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy. Curr Stem Cell Res Ther. 2006;1:213-229.
9. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17:545-580.
10. Gildehaus FJ, Haasters F, Drosse I, et al. Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo. Mol Imaging Biol. 2011;13:1204-1214.
11. Rodriguez-Porcel M. In vivo imaging and monitoring of transplanted stem cells: clinical applications. Curr Cardiol Rep. 2010;12:51-58.
12. Kircher MF, Gambhir SS, Grimm J. Noninvasive cell-tracking methods. Nat Rev Clin Oncol. 2011;8:677-688.
13. Siessmeier T, Zhou Y, Buchholz HG, et al. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med. 2005;46:964-972.
14. 18F]fallypride to dopamine D2/3 receptors in brain of living mouse. Synapse. 2010;64:313-322.
15. Liang Q, Satyamurthy N, Barrio JR, et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther. 2001;8:1490-1498.
16. Brader P, Serganova I, Blasberg RG. Noninvasive molecular imaging using reporter genes. J Nucl Med. 2013;54:167-172.
17. Serganova I, Ponomarev V, Blasberg RG. Radionuclide-based reporter gene imaging: pre-clinical and clinical implementation and application. Nucl Med Rev. 2012;15(suppl C):C20-C36.
18. Serganova I, Ponomarev V, Blasberg R. Human reporter genes: potential use in clinical studies. Nucl Med Biol. 2007;34:791-807.
19. Kummer C, Winkeler A, Dittmar C, et al. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector. Mol Imaging. 2007;6:181-192.
20. Böcker W, Yin Z, Drosse I, et al. Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med. 2008;12:1347-1359.
21. Böcker W, Rossmann O, Docheva D, Malterer G, Mutschler W, Schieker M. Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells. J Gene Med. 2007;9:585-595.
22. 18F]-DMFP infusions. Synapse. 2012;66:705-713.
23. Ichise M, Ballinger JR, Golan H, et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med. 1996;37:513-520.
24. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283-294.
25. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10:709-716.
26. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells-their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25:2739-2749.
27. Love Z, Wang F, Dennis J, et al. Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med. 2007;48:2011-2020.
28. Lee SW, Padmanabhan P, Ray P, et al. Stem cell-mediated accelerated bone healing observed with in vivo molecular and small animal imaging technologies in a model of skeletal injury. J Orthop Res. 2009;27:295-302.
29. Menon LG, Pratt J, Yang HW, Black PM, Sorensen GA, Carroll RS. Imaging of human mesenchymal stromal cells: homing to human brain tumors. J Neurooncol. 2012;107:257-267.
30. Van Damme A, Thorrez L, Ma L, et al. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells. 2006;24:896-907.
31. 11C]FLB 457 as reporter probe in living rats. Nucl Med Commun. 2005;26:259-268.
32. Chatziioannou AF, Cherry SR, Shao Y, et al. Performance evaluation of micro-PET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med. 1999;40:1164-1175.
33. Pei Z, Lan X, Cheng Z, et al. A multimodality reporter gene for monitoring transplanted stem cells. Nucl Med Biol. 2012;39:813-820.
34. 11C]-(1)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Synapse. 2012;66:489-500.
35. Hung SC, Deng WP, Yang WK, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res. 2005;11:7749-7756.
36. Biffi A, Montini E, Lorioli L, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341:1233158.
37. Aiuti A, Biasco L, Scaramuzza S, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science. 2013;341:1233151.
38. Duarte S, Carle G, Faneca H, de Lima MC, Pierrefite-Carle V. Suicide gene therapy in cancer: where do we stand now? Cancer Lett. 2012;324:160-170.